Extra-Aortic Identifiers to Guide Genetic Testing in Familial Thoracic Aortic Aneurysms and Dissections Syndromes It Is All About the Company One Keeps

被引:2
作者
Arbustini, Eloisa [1 ]
Narula, Nupoor [1 ]
机构
[1] IRCCS Fdn Policlin San Matteo, Ctr Inherited Cardiovasc Dis, I-27100 Pavia, Italy
关键词
aorta; aneurysm; genetics; cerebrovascular disorders; SMAD3; LOEYS-DIETZ SYNDROME; MARFAN-SYNDROME; OSTEOARTHRITIS SYNDROME; ROOT DILATION; MUTATIONS; LOSARTAN; DYSFUNCTION; RATIONALE; DESIGN; TRIAL;
D O I
10.1016/j.jacc.2012.03.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:404 / 407
页数:4
相关论文
共 23 条
  • [1] SMAD4 Mutation Segregating in a Family With Juvenile Polyposis, Aortopathy, and Mitral Valve Dysfunction
    Andrabi, Sara
    Bekheirnia, Mir Reza
    Robbins-Furman, Patricia
    Lewis, Richard Alan
    Prior, Thomas W.
    Potocki, Lorraine
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (05) : 1165 - 1169
  • [2] Signal transduction by the TGF-β superfamily
    Attisano, L
    Wrana, JL
    [J]. SCIENCE, 2002, 296 (5573) : 1646 - 1647
  • [3] Angiotensin II blockade and aortic-root dilation in Marfan's syndrome
    Brooke, Benjamin S.
    Habashi, Jennifer P.
    Judge, Daniel P.
    Patel, Nishant
    Loeys, Bart
    Dietz, Harry C., III
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) : 2787 - 2795
  • [4] Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2)
    Disabella, Eliana
    Grasso, Maurizia
    Gambarin, Fabiana Isabella
    Narula, Nupoor
    Dore, Roberto
    Favalli, Valentina
    Serio, Alessandra
    Antoniazzi, Elena
    Mosconi, Mario
    Pasotti, Michele
    Odero, Attilio
    Arbustini, Eloisa
    [J]. HEART, 2011, 97 (04) : 321 - 326
  • [5] The new Ghent criteria for Marfan syndrome: what do they change?
    Faivre, L.
    Collod-Beroud, G.
    Ades, L.
    Arbustini, E.
    Child, A.
    Callewaert, B. L.
    Loeys, B.
    Binquet, C.
    Gautier, E.
    Mayer, K.
    Arslan-Kirchner, M.
    Grasso, M.
    Beroud, C.
    Hamroun, D.
    Bonithon-Kopp, C.
    Plauchu, H.
    Robinson, P. N.
    De Backer, J.
    Couckek, P.
    Francke, U.
    Bouchot, O.
    Wolf, J. E.
    Stheneur, C.
    Hanna, N.
    Detaint, D.
    De Paepe, A.
    Boileau, C.
    Jondeauv, G.
    [J]. CLINICAL GENETICS, 2012, 81 (05) : 433 - 442
  • [6] Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations
    Gambarin, Fabiana I.
    Favalli, Valentina
    Serio, Alessandra
    Regazzi, Mario
    Pasotti, Michele
    Klersy, Catherine
    Dore, Roberto
    Mannarino, Savina
    Vigano, Mario
    Odero, Attilio
    Amato, Simona
    Tavazzi, Luigi
    Arbustini, Eloisa
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2009, 10 (04) : 354 - 362
  • [7] Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections
    Guo, Dong-Chuan
    Pannu, Hariyadarshi
    Tran-Fadulu, Van
    Papke, Christina L.
    Yu, Robert K.
    Avidan, Nili
    Bourgeois, Scott
    Estrera, Anthony L.
    Safi, Hazim J.
    Sparks, Elizabeth
    Amor, David
    Ades, Lesley
    McConnell, Vivienne
    Willoughby, Colin E.
    Abuelo, Dianne
    Willing, Marcia
    Lewis, Richard A.
    Kim, Dong H.
    Scherer, Steve
    Tung, Poyee P.
    Ahn, Chul
    Buja, L. Maximilian
    Raman, C. S.
    Shete, Sanjay S.
    Milewicz, Dianna M.
    [J]. NATURE GENETICS, 2007, 39 (12) : 1488 - 1493
  • [8] Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
    Habashi, JP
    Judge, DP
    Holm, TM
    Cohn, RD
    Loeys, BL
    Cooper, TK
    Myers, L
    Klein, EC
    Liu, GS
    Calvi, C
    Podowski, M
    Neptune, ER
    Halushka, MK
    Bedja, D
    Gabrielson, K
    Rifkin, DB
    Carta, L
    Ramirez, F
    Huso, DL
    Dietz, HC
    [J]. SCIENCE, 2006, 312 (5770) : 117 - 121
  • [9] 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
    Hiratzka, Loren F.
    Bakris, George L.
    Beckman, Joshua A.
    Bersin, Robert M.
    Carr, Vincent F.
    Casey, Donald E., Jr.
    Eagle, Kim A.
    Hermann, Luke K.
    Isselbacher, Eric M.
    Kazerooni, Ella A.
    Kouchoukos, Nicholas T.
    Lytle, Bruce W.
    Milewicz, Dianna M.
    Reich, David L.
    Sen, Souvik
    Shinn, Julie A.
    Svensson, Lars G.
    Williams, David M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (14) : E27 - E129
  • [10] Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
    Lacro, Ronald V.
    Dietz, Harry C.
    Wruck, Lisa M.
    Bradley, Timothy J.
    Colan, Steven D.
    Devereux, Richard B.
    Klein, Gloria L.
    Li, Jennifer S.
    Minich, L. LuAnn
    Paridon, Stephen M.
    Pearson, Gail D.
    Printz, Beth F.
    Pyeritz, Reed E.
    Radojewski, Elizabeth
    Roman, Mary J.
    Saul, J. Philip
    Stylianou, Mario P.
    Mahony, Lynn
    [J]. AMERICAN HEART JOURNAL, 2007, 154 (04) : 624 - 631